glp-1 weight-loss drugs World Health Organization issues first-ever guidelines for use of weight loss medications Understanding Weight Loss Medications: GLP-1
Description
It remains unclear, however, whether such effects mitigate hypoxia risk and ultimately fibrosis and nephron loss as described below
N Engl J Med (2021) 384:9891002
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
Davies NM, Holmes MV, Davey Smith G
Glucagon-like peptide-1 class drugs show clear protective effects in Parkinsons and Alzheimers disease clinical trials: A revolution in the making
Adverse Effects The most common adverse effects are upper respiratory tract infection, nasopharyngitis, and headache
